Sunday, June 19, 2011 |
18:00:00 |
Registration and Poster Setup |
|
Monday, June 20, 2011 |
08:00:00 |
Registration |
|
08:05:00 |
Poster Setup |
|
08:25:00 |
Introductory Plenary Session |
|
08:30:00 |
Directors’ introductory remarks |
|
08:35:00 |
What is to be learned from ancient DNA? |
Eske Willerslev
|
09:05:00 |
Implementing complex biological therapies in academic centers |
Malcolm K Brenner
|
09:35:00 |
Cell therapy for myocardial refractory ischemia with bone-marrow derived CD133+ cells: translational path and preliminary results |
Giulio Pompilio
|
10:05:00 |
Coffee Break |
|
10:15:00 |
Inauguration of the conference |
|
10:30:00 |
Variogenomics–human individual variation as the cornerstone of next-generation genomics |
Doron Lancet
|
11:00:00 |
Gene geography and historical processes: Population structure of Adriatic islanders |
Pavao Rudan
|
11:30:00 |
DNA evidence in high profile cases |
Henry Lee
|
12:15:00 |
Adjourn |
|
12:30:00 |
Sponsor Exhibit Opening and Poster Presentation |
|
14:55:00 |
Parallel Session | Forensic Science 1 |
|
14:55:00 |
Parallel Session | Biomathematical Modeling and Cancer Immunotherapy 1 |
|
15:00:00 |
Introduction from the chair |
Henry Lee
|
15:00:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Introduction from the chair |
Gunnar Kvalheim
|
15:05:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Overview of Workshop goals |
Yuri Kogan
|
15:05:00 |
From dust to dust | Forensic DNA analysis |
Dragan Primorac
|
15:20:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Dendritic cell vaccination in leukemia and AIDS |
Zwi Berneman
|
15:50:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | A validated mathematical model of systemic IL-21 immunotherapy in solid cancer |
Moran Elishmereni
|
16:05:00 |
Identification of missing persons and mass disaster victims by DNA |
|
16:20:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Increasing safety and practicality of cell-based immunotherapy |
Malcolm K Brenner
|
16:35:00 |
Second generation sequencing allows for mtDNA mixture deconvolution and high resolution detection of heteroplasmy |
Mitchell Holland
|
16:50:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | YIA/Oral Presentation |
|
17:05:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Mathematical modeling and optimal control of dendritic cell transfection cancer immunotherapy |
Filippo Castiglione
|
17:05:00 |
Perspectives and pitfalls of mRNA profiling for identification of menstrual blood and vaginal secretion |
Henry Lee
|
17:35:00 |
Classification of three-and four-person forensic mixtures |
|
17:35:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | New systems biology tools for cancer diagnostics |
Samuel Volchenboum
|
18:05:00 |
Discussion |
|
18:05:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Discussion |
|
18:10:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Poster presentation I |
|
19:30:00 |
Biomathematical Modeling and Cancer Immunotherapy 1 | Meet the Professor I, wine and cheese |
|
Tuesday, June 21, 2011 |
08:25:00 |
Parallel Session | Molecular Medicine 1 |
|
08:25:00 |
Parallel Session | Legal and Ethical Aspects of DNA Forensic Analysis |
|
08:30:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | Introduction from the chair |
|
08:30:00 |
Molecular Medicine 1 | Introduction from the chair |
|
08:35:00 |
Molecular Medicine 1 | Clinical genetics in individualized medicine |
Dusica Babovic-Vuksanovic
|
08:35:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | Forensic analysis of DNA data banks: process, progress, and prospects |
Frederick Bieber
|
09:10:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | Kinship Matching with DNA Databases (aka “Familial Searching”): Legal and Ethical Arguments |
David Kaye
|
09:10:00 |
Molecular Medicine 1 | High-throughput sequencing of complete human mtDNA genomes: insights into population history and heteroplasmy |
Mark Stoneking
|
09:45:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | International perspectives on DNA databases |
Christopher Asplen
|
09:45:00 |
Molecular Medicine 1 | HLA polymorphism, disease susceptibilty, and pharmacogenetics |
Henry Erlich
|
10:20:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | Increasing role of forensic DNA testing in legal/judicial process |
|
10:20:00 |
Molecular Medicine 1 | YIA/Selected Oral Presentation |
|
10:35:00 |
Molecular Medicine 1 | Systems glycobiology: From genome to glycome an integrated strategy for identifying and screening potential clinical markers |
Pauline Rudd
|
10:55:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | Legal and ethical aspects of bloodstain pattern evidence |
Carol Henderson
|
11:10:00 |
Molecular Medicine 1 | Gene therapy for bone and cartilage healing |
Christopher Evans
|
11:30:00 |
Legal and Ethical Aspects of DNA Forensic Analysis | Discussion |
|
11:45:00 |
Molecular Medicine 1 | Discussion |
|
14:55:00 |
Parallel Session | Anthropological Genetics |
|
14:55:00 |
Parallel Session | Biomathematical Modeling and Cancer Immunotherapy 2 |
|
15:00:00 |
Anthropological Genetics | Introduction from the chair |
Pavao Rudan
|
15:00:00 |
Biomathematical Modeling and Cancer Immunotherapy 2 | Introduction from the chair |
Filippo Castiglione
|
15:05:00 |
Anthropological Genetics | Gene geography and historical processes: Population structure of Adriatic islanders |
Pavao Rudan
|
15:05:00 |
Biomathematical Modeling and Cancer Immunotherapy 2 | Predicting effect of prostate cancer immunotherapy by personalized mathematical models |
Karin HaLevi
|
15:35:00 |
Anthropological Genetics | Famous DNA lineages from the perspective of archaeogenetics and genetic genealogy |
Daniel Vanek
|
15:40:00 |
Biomathematical Modeling and Cancer Immunotherapy 2 | Dendritic cell based cancer vaccines targeting tumor stem cells |
Gunnar Kvalheim
|
16:05:00 |
Anthropological Genetics | An attempt to place the Balkans on the canvas of genetic variation of West Eurasia and North Africa |
Richard Villems
|
16:15:00 |
Biomathematical Modeling and Cancer Immunotherapy 2 | Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics |
Yuri Kogan
|
16:35:00 |
Anthropological Genetics | Basques in the genetic landscape of Europe |
Kristin Young
|
16:50:00 |
Biomathematical Modeling and Cancer Immunotherapy 2 | Impairment of cellular immunity in human cancer |
Stanimir Vuk-Pavlovic
|
17:05:00 |
Anthropological Genetics | DNA of ancient skeletal remains from old Bosnian graves |
Damir Marjanović
|
17:25:00 |
Biomathematical Modeling and Cancer Immunotherapy 2 | Discussion and drafting conclusions |
|
17:35:00 |
Anthropological Genetics | Personal genomics services (PGS): Digitalization of expert genetic knowledge and possible consequences |
Daniela Steinberger
|
18:05:00 |
Anthropological Genetics | Discussion |
|
20:00:00 |
Welcome Reception |
|
20:20:00 |
Conferring Young Investigator Awards |
|
Wednesday, June 22, 2011 |
09:00:00 |
Half-day excursion |
|
18:00:00 |
ISABS Annual Meeting |
|
Thursday, June 23, 2011 |
08:25:00 |
Parallel Session | Forensic Science 2 | Workshop on Legislation Pertinent to DNA Databases |
|
08:25:00 |
Parallel Session | Advances in Noninvasive Prenatal Diagnosis in First Trimester |
|
08:30:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Introduction from the chair |
Eliezer Shalev
|
08:30:00 |
Forensic Science 2 | Introduction from the chair |
|
08:35:00 |
Forensic Science 2 | A retrospective analysis of cold-case investigations |
Henry Lee
|
08:35:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Early prenatal diagnosis–an overview |
Eliezer Shalev
|
09:05:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Early fetal 3D ultrasound examination |
Ron Tepper
|
09:10:00 |
Forensic Science 2 | Chimerism and forensics – Examples and importance |
|
09:35:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Genetic approach in increased nuchal translucency and normal karyotype |
Stavit A. Shalev
|
09:45:00 |
Forensic Science 2 | Non-human forensic genetics |
Henry Lee
|
10:05:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Free nucleic acids in maternal blood for noninvasive prenatal diagnosis |
Esther Guetta
|
10:20:00 |
Forensic Science 2 | Cat coat pattern tabby and tick / mtDNA genome |
Henry Lee
|
10:35:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | YIA/Selected Oral Presentation |
|
10:50:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Fetal free nucleic acids in maternal blood vs. ultrasound markers in Down Syndrome screening |
Symcha Yagel
|
10:50:00 |
Forensic Science 2 | Post mortem pharmacogenomics |
Henry Lee
|
10:55:00 |
Forensic Science 2 | YIA/Selected Presentation |
|
11:10:00 |
Forensic Science 2 | Molecular autopsy in New York City Office of Chief Medical Examiner |
|
11:20:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | CEP as innovative method for isolation of fetal nucleated red blood cells for noninvasive prenatal diagnosis |
Ofer Klein
|
11:50:00 |
Forensic Science 2 | Discussion |
|
11:50:00 |
Advances in Noninvasive Prenatal Diagnosis in First Trimester | Discussion |
|
11:55:00 |
Sponsor's Lecture |
|
12:00:00 |
Optimization of the forensic workflow with innovations from Promega: automated sample prep and new kits for STR-Analysis |
|
14:55:00 |
Parallel Session | ESF Workshop on protein glycosylation in diagnostics and therapy |
|
14:55:00 |
Parallel Session | Cell Therapy |
|
15:00:00 |
Cell Therapy | Introduction from the chair |
Andre Terzic
|
15:00:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Introduction from the chair |
Nicolai Bovin
|
15:05:00 |
Cell Therapy | Stem cell platforms for heart repair |
Andre Terzic
|
15:05:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Diagnostic potential of antiglycan autoantibodies |
Nicolai Bovin
|
15:35:00 |
Cell Therapy | Adult stem cells as biologics delivery platform for ischemic injury |
Robert Deans
|
15:35:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Congenital disorders of glycosylation, from genotypes to therapies |
Thierry Hennet
|
16:05:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Complex genetics of protein glycosylation |
Gordan Lauc
|
16:05:00 |
Cell Therapy | Mechanisms and strategies to improve cardiovascular cell therapy |
Marc Pennacino
|
16:35:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | GWAS analysis of the human plasma glycome |
Igor Rudan
|
16:35:00 |
Cell Therapy | Cell therapy for myocardial refractory ischemia with bone-marrow derived CD133+ cells: translational path and preliminary results |
Giulio Pompilio
|
17:05:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Glycosylation profiling for biomarker discovery of autoimmune and alloimune diseases |
Manfred M. Wuhrer,
|
17:05:00 |
Cell Therapy | Induced pluripotent stem cells and embryonic stem cells for discovery and therapy |
Mahendra Rao
|
17:35:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Galectin binding glycoforms of serum proteins, a functional biomarker in cancer and inflammation |
Hakon Leffler
|
17:35:00 |
Cell Therapy | Regeneration of cartilage defects by gene-based approaches and tissue engineering |
Henning Madry
|
18:05:00 |
Cell Therapy | Discussion |
|
18:05:00 |
ESF Workshop on protein glycosylation in diagnostics and therapy | Discussion |
|
18:10:00 |
Cell Therapy | Poster presentation II |
|
19:30:00 |
Cell Therapy | Meet the Professor II, wine and cheese |
|
Friday, June 24, 2011 |
08:25:00 |
Parallel Session | NextGen Sequencing |
|
08:25:00 |
Parallel Session | Molecular Medicine 2 |
|
08:30:00 |
NextGen Sequencing | Introduction from the chair |
|
08:30:00 |
Molecular Medicine 2 | Introduction from the chair |
Christopher Evans
|
08:35:00 |
Molecular Medicine 2 | Advances in Molecular Diagnostics: Role of Nanotechnology and Future Perspectives |
Arezou Ghazani
|
08:35:00 |
NextGen Sequencing | The Next Generation Sequencing Revolution |
David I. Smith
|
09:05:00 |
NextGen Sequencing | Next Generation Sequencing of oropharingeal cancers |
David I. Smith
|
09:15:00 |
Molecular Medicine 2 | Nutrigenetics and nutrigenomics in personalized nutrition and medicine |
Artemis Simopoulos
|
09:35:00 |
NextGen Sequencing | Resolution of DNA mixtures and degraded DNA by Next-Generation Sequencing |
Cassandra Calloway
|
09:45:00 |
Molecular Medicine 2 | Prediction of pathophenotype through transcriptome deconvolution |
Carmen Terzic
|
10:05:00 |
NextGen Sequencing | Integration of multiple data types obtained from genomics experiments: challenges and opportunities |
Jean-Pierre Kocher
|
10:20:00 |
Molecular Medicine 2 | A practical immunocompetent animal model of hepatitis C viral infection |
George Wu
|
10:35:00 |
NextGen Sequencing | YIA/Selected Oral Presentation |
|
10:50:00 |
NextGen Sequencing | Molecularly defined cancer subtypes using NextGen Sequencing |
George Vasmatzis
|
10:55:00 |
Molecular Medicine 2 | Gene therapy for arthritis |
Christopher Evans
|
11:20:00 |
NextGen Sequencing | Clinical NextGen Sequencing of hereditary colon cancer genes |
Matthew Ferber
|
11:30:00 |
Molecular Medicine 2 | Virus-host interactions: The role of microRNA in tumorigenesis and immune evasion |
Giorgio Palù
|
11:50:00 |
NextGen Sequencing | Discussion |
|
12:05:00 |
Molecular Medicine 2 | Discussion |
|
12:30:00 |
Poster removal |
|
13:25:00 |
Concluding Plenary Session |
|
13:35:00 |
A day at the Human Cell Therapy Laboratory, Mayo Clinic |
Dennis Gastineau
|
14:05:00 |
YIA/Selected Oral Presentation |
|
14:20:00 |
In search of novel types of antibiotics by targeting bacterial mechanosensitive channels |
Boris Martinac
|
14:50:00 |
High-throughput technology for biomedical science in Croatia |
Kresimir Pavelic
|
15:20:00 |
Discussion |
|
15:25:00 |
Conclusion of the Conference |
|
15:30:00 |
Announcement of the next ISABS Conference |
|